Kostas I Arvanitidis

Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19*17 discovery: the case of Greece.

V. Manolopoulos, G. Ragia, A. Tavridou, 2009, Pharmacogenomics.

Endothelial nitric oxide synthase gene polymorphisms -786T >C and 894G >T in coronary artery bypass graft surgery patients

S. Kanoni, G. Dedoussis, V. Manolopoulos, 2010, Human Genomics.

Genetic polymorphisms of drug‐metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population

V. Manolopoulos, G. Ragia, A. Tavridou, 2007, Fundamental & clinical pharmacology.

Renin-angiotensin-aldosterone system gene polymorphisms in coronary artery bypass graft surgery patients

S. Kanoni, G. Dedoussis, V. Manolopoulos, 2010, Journal of the renin-angiotensin-aldosterone system : JRAAS.

The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes.

V. Manolopoulos, A. Tavridou, K. Arvanitidis, 2010, Clinica chimica acta; international journal of clinical chemistry.

The -759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians

V. Manolopoulos, A. Tavridou, K. Arvanitidis, 2008, Pharmacogenetics and genomics.